ContextVision AB (publ) (0L8Z) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Contextvision Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.554 -- 00:00:05.639 Welcome to Context Vision and welcome to the fourth quarter and full year 2025 00:00:05.639 -- 00:00:12.083 report. Today with Richard Hallström, our CFO, myself, Gerald. 00:00:12.225 -- 00:00:15.428 The transformation of Context Vision is in full swing. 00:00:15.428 -- 00:00:20.813 So we're combining image quality and data quality into a quantitative imaging 00:00:20.813 -- 00:00:22.614 business. 00:00:22.614 -- 00:00:27.759 Our fourth quarter saw early signs of stabilization in the market, but also 00:00:27.759 -- 00:00:30.039 in our business. 00:00:31.013 -- 00:00:36.507 We have enrolled our first patient in a clinical study to collect data 00:00:36.507 -- 00:00:40.156 and test our new data quality products. 00:00:40.156 -- 00:00:46.547 We have launched a new series of clinical products at RSNA 2025 00:00:46.853 -- 00:00:49.776 back in November in Chicago. 00:00:50.065 -- 00:00:55.552 And if we look to our financial results, the fourth quarter came in at 31.7 00:00:55.552 -- 00:01:00.638 million SEC. If we exclude Valuta impacts, this is a minor 00:01:00.638 -- 00:01:02.140 growth 00:01:02.140 -- 00:01:07.146 and rolls up to 110.3 million SEC for the year. 00:01:07.146 -- 00:01:11.312 So quite a positive development in the last quarter that we've seen. 00:01:11.312 -- 00:01:14.573 Likewise, our margins, 24.9% 00:01:14.696 -- 00:01:17.998 for the fourth quarter are recovering. 00:01:18.702 -- 00:01:24.369 If we look to earnings per shares, we closed the year with a black zero, despite changes 00:01:24.369 -- 00:01:29.855 that we made in our sales and marketing team, and I'll talk to that in a minute. 00:01:29.855 -- 00:01:34.941 So overall, 2025 has been a demanding year for healthcare and 00:01:34.941 -- 00:01:40.528 the medical...